Celon Pharma S.A announced it has signed a non-binding term sheet of 2,700,000 shares at issue price PLN 15 per share for gross proceeds PLN 40,500,000 on May 22, 2024. The transaction includes participation from new investor, Tang Capital Management, LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.68 PLN | -0.88% |
|
+1.69% | +1.42% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.42% | 198M | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- CLN Stock
- News Celon Pharma S.A.
- Celon Pharma S.A. announced that it expects to receive PLN 40.5 million in funding from Tang Capital Management, LLC